Susquehanna International Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-96,985
| Closed | -$42K | – | 7182 |
|
|
2022
Q3 | $42K | Buy |
96,985
+50,855
| +110% | +$22K | ﹤0.01% | 5553 |
|
|
2022
Q2 | $39K | Sell |
46,130
-25,682
| -36% | -$21.7K | ﹤0.01% | 5304 |
|
|
2022
Q1 | $396K | Sell |
71,812
-17,067
| -19% | -$94.1K | ﹤0.01% | 4007 |
|
|
2021
Q4 | $860K | Buy |
88,879
+44,450
| +100% | +$430K | ﹤0.01% | 3054 |
|
|
2021
Q3 | $794K | Buy |
44,429
+12,043
| +37% | +$215K | ﹤0.01% | 3054 |
|
|
2021
Q2 | $791K | Buy |
+32,386
| New | +$791K | ﹤0.01% | 3311 |
|
|
2021
Q1 | – | Sell |
-24,349
| Closed | -$185K | – | 5945 |
|
|
2020
Q4 | $185K | Buy |
+24,349
| New | +$185K | ﹤0.01% | 4298 |
|
|
2020
Q3 | – | Sell |
-14,128
| Closed | -$84K | – | 5168 |
|
|
2020
Q2 | $84K | Sell |
14,128
-4,448
| -24% | -$26.4K | ﹤0.01% | 3944 |
|
|
2020
Q1 | $83K | Buy |
+18,576
| New | +$83K | ﹤0.01% | 4094 |
|
|
2019
Q4 | – | Sell |
-16,656
| Closed | -$131K | – | 5047 |
|
|
2019
Q3 | $131K | Buy |
16,656
+1,906
| +13% | +$15K | ﹤0.01% | 4007 |
|
|
2019
Q2 | $232K | Buy |
+14,750
| New | +$232K | ﹤0.01% | 3753 |
|